(19)
(11) EP 0 960 334 A1

(12)

(43) Date of publication:
01.12.1999 Bulletin 1999/48

(21) Application number: 97952553.0

(22) Date of filing: 19.12.1997
(51) International Patent Classification (IPC): 
G01N 33/ 53( . )
A61K 39/ 395( . )
A61P 9/ 00( . )
A61P 43/ 00( . )
C07K 14/ 52( . )
C07K 16/ 24( . )
C12N 15/ 09( . )
G01N 33/ 566( . )
A61K 38/ 00( . )
A61K 45/ 00( . )
A61P 35/ 00( . )
C07K 14/ 485( . )
C07K 14/ 71( . )
C07K 19/ 00( . )
C12P 21/ 02( . )
G01N 33/ 74( . )
(86) International application number:
PCT/US1997/023533
(87) International publication number:
WO 1998/028621 (02.07.1998 Gazette 1998/26)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 20.12.1996 US 19960033697P

(71) Applicants:
  • LUDWIG INSTITUTE FOR CANCER RESEARCH
    New York, New York 10158 (US)
  • HELSINKI UNIVERSITY LICENSING LTD. OY
    00710 Helsinki (FI)

(72) Inventors:
  • KORPELAINEN, Eija
    FIN-00360 Helsinki (FI)
  • GUNJI, Yuji
    FIN-00290 Helsinki (FI)
  • ALITALO, Kari
    FIN-02100 Espoo (FI)
  • OLOFSSON, Birgitta
    S-117 Stockholm (SE)
  • ERIKSSON, Ulf
    S-746 34 Balsta (SE)

(74) Representative: Allen, Philippa Margaret, et al 
Markgraaf Patents Limited The Crescent 54 Blossom Street
York YO24 1AP
York YO24 1AP (GB)

   


(54) VEGF-B/RECEPTOR COMPLEX AND USES THEREOF